Alphabet Inc.
COMPOSITIONS AND METHODS FOR COMMON COLDS

Last updated:

Abstract:

This disclosure relates to pharmaceutical compositions for preventing, treating, reducing the duration, or reducing the severity of symptoms of the common cold. The pharmaceutical composition can comprise a probiotic formulation of non-pathogenic bacteria, vitamin C and vitamin D along with a pharmaceutically acceptable excipient or filler. A method of for preventing, treating, reducing the duration, or reducing the severity of symptoms of the common cold is also disclosed in which a patient in need of a treatment for preventing, treating, reducing the duration, or reducing the severity of symptoms of the common cold is identified. The pharmaceutical composition can then be administered orally to the patient.

Status:
Application
Type:

Utility

Filling date:

17 Jan 2018

Issue date:

31 Oct 2019